Analyzing the options chain and the chart patterns of AUPH Aurinia Pharmaceuticals prior to the earnings report this week, I would consider purchasing the 7usd strike price Calls with an expiration date of 2024-3-15, for a premium of approximately $1.50. If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
$AUPH AUPH inside days after good run up and decent beat. Liquid and increasing institutional interest.
Price has broken out of a down channel I see this breaking down slightly back into the channel, forming a right shoulder along the yellow horizontal and then continuing to pursue the reversal above the channel Lets see what happens on this Weekly chart Bars pattern in green shows my idea
After a month of sideways chop, perfectly contained by 7.67 & 6.99 (ORANGE), we now have a path towards higher levels at 10.23 (RED dotted line). S/R's.
A comparison chart, between two very different asset classes Yet they are quite similar structurally. Thought it was interesting, hope you do also.
41% retracement from head to neckline, so 41% from neckline puts it at $10.50. There are multiple horizontal support zones, see chart that also correspond to this zone $9.50 - 10.50. Greenleaf (CEO) is a complete clown. Issuing a statement last week that guidance will likely be aggressive then he issued guidance that was approximately 30% below the analysts. ...
NASDAQ:AUPH Possible Scenario: LONG Evidence: Price Action, I'm pretty sure about it, this is one of my main positions early morning. I expect it hit the Fibo level 100% at 25$ this week, most likely tomorrow Call options, strike 25$, 10/15/2021. *This is my idea and could be wrong 100%.
You can buy AUPH target 24 stop loss 17.39 Money management your responsibility. I recommend entering a maximum of 10% of the portfolio. Good luck
Tons of money to played in this, constant up and down trend. Either short when it hits the channel trend line top, or go long at the channel bottom... I would rather be the bull in this situation though... so I would hold out on a entry.
NASDAQ:AUPH Possible Scenario: LONG Evidence: Price Action TP1~ 12.5$. TP2 ~14.25$ Call options, Strike 14$, 07/16/21 Call options, Strike 15$, 07/16/21 * This is my idea and could be wrong 100%
NASDAQ:AUPH will stabilize after the stock dilution and continue to its true value in the teens. Buy on the dip. ir.auriniapharma.com ir.auriniapharma.com
AUPH to hold for greater gains in the near future. See comments on chart for more information. No BUY or SELL targets.
We formed an ascending triangle as we approached resistance at $6.60. We have appeared to break above the top level in a bullish manner which could result in a bullish afternoon if we do not retrace back below $6.60. Hopefully, this trend will continue throughout the end of the day and into next week.
AUPH has great science, the only trouble that they had were deaths that were determined not to be caused by the drug. They are treating lupus, deaths are going to happen. Whether you are long or short on it, it has been set-up for a great day for Tuesday. News was announced Monday that they have been selected to present at two different medical conferences. Their...